FENNEC PHARMACEUTICALS INC. — Director's Dealing 2026

Feb 20, 2026

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: FENNEC PHARMACEUTICALS INC. (FENC)
CIK: 0001211583
Period of Report: 2026-02-18

Reporting Person: Hackman Jeffrey S. (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2026-02-18	Common Shares	M	13710	—	Acquired	28710	Direct

Footnotes

F1: Represents settlement of PSUs that vested on February 18, 2026.